investor paintrials.com

CORPORATE OVERVIEW Pain Therapeutics, Inc.

The Investor Relations website contains information about Pain Therapeutics, Inc.s business for stockholders, potential investors, and financial analysts.
traffic

OVERVIEW

The web site investor.paintrials.com presently has an average traffic classification of zero (the lower the superior). We have analyzed sixteen pages inside the web site investor.paintrials.com and found thirty-five websites linking to investor.paintrials.com.
Pages Parsed
16
Links to this site
35

INVESTOR.PAINTRIALS.COM TRAFFIC

The web site investor.paintrials.com is seeing variant quantities of traffic for the duration of the year.
Traffic for investor.paintrials.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.paintrials.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.paintrials.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

WHAT DOES INVESTOR.PAINTRIALS.COM LOOK LIKE?

Desktop Screenshot of investor.paintrials.com Mobile Screenshot of investor.paintrials.com Tablet Screenshot of investor.paintrials.com

INVESTOR.PAINTRIALS.COM SERVER

Our crawlers revealed that a single root page on investor.paintrials.com took two thousand and sixty-eight milliseconds to load. Our crawlers could not observe a SSL certificate, so therefore I consider investor.paintrials.com not secure.
Load time
2.068 sec
SSL
NOT SECURE
IP
23.55.218.214

BROWSER IMAGE

SERVER SOFTWARE AND ENCODING

We revealed that investor.paintrials.com is using the nginx operating system.

HTML TITLE

CORPORATE OVERVIEW Pain Therapeutics, Inc.

DESCRIPTION

The Investor Relations website contains information about Pain Therapeutics, Inc.s business for stockholders, potential investors, and financial analysts.

PARSED CONTENT

The web site states the following, "is a biopharmaceutical company that develops novel drugs." I noticed that the web site also stated " 1238 AM EDT on Mar 30, 2018." They also said " Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER. FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of August 7, 2018."

ANALYZE SIMILAR BUSINESSES

Pandora - Investor Relations - Corporate Overview

Click here to add this event to your calendar. at Pacific Crest Global Technology Leadership Forum. at Pacific Crest Global Technology Leadership Forum.

PANDORA - Investor Relations

Vice President, Head of Investor Relations. Transactions in connection with share buyback programme. Transactions in connection with share buyback programme. Interim Report for the first quarter 2018.

Investor Home Page Parexel

Randomization and Trial Supply Management. Strategic Compliance and Risk Management. Where People Make the Difference. PAREXEL makes contributing to medical advances possible. Strong individually, stronger as a company. Find a rewarding career path. Not just a passion - a way of life.

investor.patrizia.ag

Für diese Domain steht momentan keine Website zur Verfügung.

Financial News Releases

Paychex Schedules Third Quarter Fiscal 2018 Earnings Release and Webcast.